Current Challenges and New Opportunities in Follicular Lymphoma

STATEMENT OF NEED Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab...
Postgraduate Institute for Medicine and i3 Health

Virtual Patient: Adult Male with Reaction to Flying Hymenoptera Sting

This patient simulation involves an adult male who had a severe reaction to a flying hymenoptera sting. Based on the clinical history and test results, the learner will choose the best way to treat the patient with immunotherapy. The learner will answer specific questions that explain the immunotherapy treatment, including risks, intervals, duration, and possibility of relapse to the patient. The learner will receive feedback for each decision that is made, and numerous references that discuss...
American Academy of Allergy, Asthma & Immunology

Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care

Improving outcomes for patients with multiple myeloma requires building on the foundation of current therapies with new agents and combinations, recognizing the nature of each individual patient’s disease, and providing a personalized approach to treatment. This activity uses evidence-based presentations and case study vignettes to present the latest information on selecting the most appropriate therapy based on patient profile, clinical evidence, and assessment of risk-versus-benefit. Le...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Significant advances in treatment with novel agents for B-cell non-Hodgkin’s lymphoma (NHL) have improved patient outcomes and survival. However, many patients are at high-risk of relapse, meriting a precision approach to reduce the rate of recurrence and improve outcomes. The identification of molecular subtypes, the persistence of clinical challenges, and the anticipated emergence of clinical data necessitate a collaborative treatment approach to ensure individualized care for patients wit...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Navigating New Options to Improve Outcomes in Multiple Myeloma

As new combinations and classes of agents emerge for the treatment of multiple myeloma (MM), community-based treatment teams require clarity on the optimal integration of recently approved and emerging agents into the relapsed/refractory landscape for MM. While high-dose chemotherapy is not appropriate for all patients, multiple options have emerged that demonstrate a clinical benefit and require proper integration into the treatment paradigm. In addition, clinicians must meet requirements for...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Fact or Fiction? Sorting Out Common Misconceptions About Ulcerative Colitis to Improve Patient Care

It is well established that ulcerative colitis (UC) is a heterogeneous disease with symptoms that wane over time. The disease course for 50% of individuals is persistently active over time with worsening and relapsing symptoms and is associated with long-term anemia, colonic dysfunction, and increased risk for colorectal cancer. Evidence indicates that treating the inflammation to achieve improvement in endoscopic appearance of the mucosa early in the course of UC is effective for current flar...
CME Outfitters

Treatment Strategies for Patients with Schizophrenia: Finding the Right Mix of Drug and Delivery to Prevent Relapse

At the end of this CE activity, participants should be able to: - Implement treatment planning with a goal of recovery in at least 60% of patients with schizophrenia. - Incorporate into practice management strategies that engage the patient and family/caregivers in improving adherence and reducing the risk of relapse in schizophrenia. - Weigh the pros and cons of oral therapies versus long-acting injectables (LAIs) in achieving recovering when developing a treatment plan for patients with s...
CME Outfitters

Crucial Conversations in Oncology Nursing: Management Considerations for the AML Patient

The landscape of AML treatment is evolving and newer targeted agents may improve outcomes for selected subgroups of patients. Oncology nursing professionals provide disease and treatment information, manage adverse effects, and offer emotional support. Knowledge of the key management issues for patients with AML is critical in fulfilling this role. Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and po...
American Academy of CME

Opioid Use Disorder in Special Populations: Making Recovery a Goal

The opioid epidemic is ravaging many parts of the United States, resulting in drug overdose deaths emerging as the leading cause of injury death. The 2015 statistics from Health and Human Services on human and economic costs were staggering, reporting that 12.5 million people misused prescription opioids that year, resulting in $78.5 billion in economic costs. Yet the National Institute on Alcohol Abuse and Alcoholism (NIAA)'s National Epidemiological Survey on Alcohol Abuse and Related Condit...
CME Outfitters

Looking at the Big Picture of IBD

The burden of inflammatory bowel diseases (IBD), of which Chroh's disease and ulcerative colitis are the primary entities, is significant and wide ranging. IBD that is not well-controlled impairs quality of life, social activities, travel and ability to work, leading to higher rates of absenteeism and permanent work disability.1,2 The idiopathic intestinal inflammation of IBD requires life-long treatment and accounts for enormous hospitalization costs. According to data from the U.S. Nationa...
Integritas Communications

Getting to Remission: Differentiating Residual Symptoms from Treatment Side Effects in Major Depressive Disorder

Millions of US adults with MDD are inadequately treated despite the availability of effective therapies. Achieving and maintaining remission continues to be a considerable clinical challenge. In addition, cognitive impairment is a common residual symptom, and many clinicians are failing to assess for and manage this aspect of depression. Some residual symptoms, such as weight gain, sleep disturbances, and sexual dysfunction, may be difficult to distinguish from treatment side effects. Despite ...

The Evolution of Multiple Myeloma Patient Management: Managing Today, Preparing for Tomorrow

The clinical multiple myeloma arena has undergone significant advances in diagnosis and prognosis, minimal residual disease monitoring, and supportive care. This expansion brings renewed hope to patients, but it presents new challenges for the clinicians charged with their care. Some patients enjoy many years in clinical remission, whereas for others survival is no more than 2 or 3 years. This reflects the heterogeneity of myeloma and underscores the inappropriateness of a one-size-fits-all ma...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Finding Feeling: Treating Traumatic Dissociation

Trauma is a both a physical and psychological disruption, a discontinuity in experience. The helplessness associated with it challenges a person’s sense of agency and therefore their customary control over mind and body. Dissociative disorders constitute a failure of integration of identity, memory, or consciousness, andmost often occur in the aftermath of trauma. A Dissociative Subtype has been added to the diagnosis of Post-Traumatic Stress Disorder the DSM-5. This requires all of the DSM-...
International Society for Traumatic Stress Studies

A 4-Year Prospective Study of Eating Disorder NOS

To examine the course of Eating Disorder NOS (EDNOS) compared with anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorder (BED). Method: Prospective study of 385 participants meeting DSM-IV criteria for AN, BN, BED and EDNOS at 3 sites. Recruitment was from the community and specialty clinics. Participants were followed at 6-month intervals over a 4-year period using the Eating Disorder Examination as the primary assessment. Results: EDNOS remitted significantly more quickly tha...

Separation Anxiety in Children & Adolescents

This CE test is based on the book "Separation Anxiety in Children & Adolescents" (2005, 298 pages). The book presents a research-based approach to understanding the challenges of separation anxiety and helping children, adolescents, and their parents build the skills they need to overcome it. The authors provide step-by-step guidelines for implementing the entire process of therapy-from intake and assessment through coping skills training, cognitive-behavioral interventions, and relapse preven...
Professional Development Resources

Substance Abuse and Dependency

Target audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors This course looks at the assessment and treatment of a variety of drug and alcohol related issues as well as an in-depth look at the behavioral and physiological effects of some of the most commonly abused drugs. Reading of the books, "Treating Alcohol and Drug Problems in Psychotherapy Practice" and "Buzzed: The Straight Facts about the Most Used and Abused Drugs from Alcohol t...
CE4Less Online CEUs for Mental Health Professionals

Substance Abuse Treatment: Addressing the Specific Needs of Women

Target Audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors Course Syllabus: * Introduction * Patterns of Use: From Initiation to Treatment * Substance Use and Birth Outcomes * Culturally Responsive Screening and Assessment * The Impact of Trauma and Prenatal Care * Substance Abuse Among Specific Population Groups * Relational Model Approach * Postpartum Relapse Prevention
CE4Less Online CEUs for Mental Health Professionals

Tobacco use and mental illness

Overview of contributing factors to the increased use of tobacco amongst individuals with mental illness. Target audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors Syllabus: * Tobacco use & mental illness * Assessment & intervention * Smoking cessation * Relapse prevention Unlimited Access to Over 200 Courses Starting at Only $74.99
CE4Less Online CEUs for Mental Health Professionals

Introduction and Overview (Section I); and The Older Adult Treatment Population (Section II): From Substance Abuse Relapse Prevention for Older Adults--A Group Treatment Approach

I. Introduction and Overview: From Substance Abuse Relapse Prevention for Older Adults—A Group Treatment Approach provides background and how-to directions for introducing relapse techniques to older clients. II. The Older Adult Treatment Population: From Substance Abuse Relapse Prevention for Older Adults—A Group Treatment Approach provides an overview of the target population for cognitive-behavioral and self-management intervention (CB/SM) for older adults who have substance use diso...

Codependency: Causes, Consequences and Cures

In this course, the author offers in-depth and in-person strategies for therapists to use in working with clients who present with the characteristic behavior patterns of codependency. Clients are usually unaware of the underlying codependency that is often responsible for the symptoms they’re suffering. Starting with emphasis on the delicate process of building a caring therapeutic relationship with these clients, the author guides readers through the early shame-inducing parenting styles t...
Professional Development Resources

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.